1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global CRISPR-Based Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Genome Editing 1.2.3 Genetic Engineering 1.2.4 gRNA Database/Gene Librar 1.2.5 CRISPR Plasmid 1.2.6 Human Stem Cells 1.2.7 Genetically Modified Organisms/Crops 1.2.8 Cell Line Engineering 1.3 Market by Application 1.3.1 Global CRISPR-Based Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Biotechnology Companies 1.3.3 Pharmaceutical Companies 1.3.4 Academic Institutes 1.3.5 Research and Development Institutes 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global CRISPR-Based Therapeutics Market Perspective (2016-2027) 2.2 CRISPR-Based Therapeutics Growth Trends by Regions 2.2.1 CRISPR-Based Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 CRISPR-Based Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 CRISPR-Based Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 CRISPR-Based Therapeutics Industry Dynamic 2.3.1 CRISPR-Based Therapeutics Market Trends 2.3.2 CRISPR-Based Therapeutics Market Drivers 2.3.3 CRISPR-Based Therapeutics Market Challenges 2.3.4 CRISPR-Based Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top CRISPR-Based Therapeutics Players by Revenue 3.1.1 Global Top CRISPR-Based Therapeutics Players by Revenue (2016-2021) 3.1.2 Global CRISPR-Based Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by CRISPR-Based Therapeutics Revenue 3.4 Global CRISPR-Based Therapeutics Market Concentration Ratio 3.4.1 Global CRISPR-Based Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by CRISPR-Based Therapeutics Revenue in 2020 3.5 CRISPR-Based Therapeutics Key Players Head office and Area Served 3.6 Key Players CRISPR-Based Therapeutics Product Solution and Service 3.7 Date of Enter into CRISPR-Based Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 CRISPR-Based Therapeutics Breakdown Data by Type 4.1 Global CRISPR-Based Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2022-2027) 5 CRISPR-Based Therapeutics Breakdown Data by Application 5.1 Global CRISPR-Based Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America CRISPR-Based Therapeutics Market Size (2016-2027) 6.2 North America CRISPR-Based Therapeutics Market Size by Type 6.2.1 North America CRISPR-Based Therapeutics Market Size by Type (2016-2021) 6.2.2 North America CRISPR-Based Therapeutics Market Size by Type (2022-2027) 6.2.3 North America CRISPR-Based Therapeutics Market Size by Type (2016-2027) 6.3 North America CRISPR-Based Therapeutics Market Size by Application 6.3.1 North America CRISPR-Based Therapeutics Market Size by Application (2016-2021) 6.3.2 North America CRISPR-Based Therapeutics Market Size by Application (2022-2027) 6.3.3 North America CRISPR-Based Therapeutics Market Size by Application (2016-2027) 6.4 North America CRISPR-Based Therapeutics Market Size by Country 6.4.1 North America CRISPR-Based Therapeutics Market Size by Country (2016-2021) 6.4.2 North America CRISPR-Based Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe CRISPR-Based Therapeutics Market Size (2016-2027) 7.2 Europe CRISPR-Based Therapeutics Market Size by Type 7.2.1 Europe CRISPR-Based Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe CRISPR-Based Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe CRISPR-Based Therapeutics Market Size by Type (2016-2027) 7.3 Europe CRISPR-Based Therapeutics Market Size by Application 7.3.1 Europe CRISPR-Based Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe CRISPR-Based Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe CRISPR-Based Therapeutics Market Size by Application (2016-2027) 7.4 Europe CRISPR-Based Therapeutics Market Size by Country 7.4.1 Europe CRISPR-Based Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe CRISPR-Based Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific CRISPR-Based Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type 8.2.1 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application 8.3.1 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region 8.4.1 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America CRISPR-Based Therapeutics Market Size (2016-2027) 9.2 Latin America CRISPR-Based Therapeutics Market Size by Type 9.2.1 Latin America CRISPR-Based Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America CRISPR-Based Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America CRISPR-Based Therapeutics Market Size by Type (2016-2027) 9.3 Latin America CRISPR-Based Therapeutics Market Size by Application 9.3.1 Latin America CRISPR-Based Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America CRISPR-Based Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America CRISPR-Based Therapeutics Market Size by Application (2016-2027) 9.4 Latin America CRISPR-Based Therapeutics Market Size by Country 9.4.1 Latin America CRISPR-Based Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America CRISPR-Based Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa CRISPR-Based Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type 10.2.1 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application 10.3.1 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country 10.4.1 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Caribou Biosciences 11.1.1 Caribou Biosciences Company Details 11.1.2 Caribou Biosciences Business Overview 11.1.3 Caribou Biosciences CRISPR-Based Therapeutics Introduction 11.1.4 Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.1.5 Caribou Biosciences Recent Development 11.2 Addgene 11.2.1 Addgene Company Details 11.2.2 Addgene Business Overview 11.2.3 Addgene CRISPR-Based Therapeutics Introduction 11.2.4 Addgene Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.2.5 Addgene Recent Development 11.3 CRISPR THERAPEUTICS 11.3.1 CRISPR THERAPEUTICS Company Details 11.3.2 CRISPR THERAPEUTICS Business Overview 11.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Introduction 11.3.4 CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.3.5 CRISPR THERAPEUTICS Recent Development 11.4 Merck KGaA 11.4.1 Merck KGaA Company Details 11.4.2 Merck KGaA Business Overview 11.4.3 Merck KGaA CRISPR-Based Therapeutics Introduction 11.4.4 Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.4.5 Merck KGaA Recent Development 11.5 Mirus Bio LLC 11.5.1 Mirus Bio LLC Company Details 11.5.2 Mirus Bio LLC Business Overview 11.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Introduction 11.5.4 Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.5.5 Mirus Bio LLC Recent Development 11.6 Editas Medicine 11.6.1 Editas Medicine Company Details 11.6.2 Editas Medicine Business Overview 11.6.3 Editas Medicine CRISPR-Based Therapeutics Introduction 11.6.4 Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.6.5 Editas Medicine Recent Development 11.7 Takara Bio USA 11.7.1 Takara Bio USA Company Details 11.7.2 Takara Bio USA Business Overview 11.7.3 Takara Bio USA CRISPR-Based Therapeutics Introduction 11.7.4 Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.7.5 Takara Bio USA Recent Development 11.8 Thermo Fisher Scientific 11.8.1 Thermo Fisher Scientific Company Details 11.8.2 Thermo Fisher Scientific Business Overview 11.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Introduction 11.8.4 Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.8.5 Thermo Fisher Scientific Recent Development 11.9 Horizon Discovery Group 11.9.1 Horizon Discovery Group Company Details 11.9.2 Horizon Discovery Group Business Overview 11.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Introduction 11.9.4 Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.9.5 Horizon Discovery Group Recent Development 11.10 Intellia Therapeutics 11.10.1 Intellia Therapeutics Company Details 11.10.2 Intellia Therapeutics Business Overview 11.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Introduction 11.10.4 Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.10.5 Intellia Therapeutics Recent Development 11.11 GE Healthcare Dharmacon 11.11.1 GE Healthcare Dharmacon Company Details 11.11.2 GE Healthcare Dharmacon Business Overview 11.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Introduction 11.11.4 GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2016-2021) 11.11.5 GE Healthcare Dharmacon Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global CRISPR-Based Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Genome Editing Table 3. Key Players of Genetic Engineering Table 4. Key Players of gRNA Database/Gene Librar Table 5. Key Players of CRISPR Plasmid Table 6. Key Players of Human Stem Cells Table 7. Key Players of Genetically Modified Organisms/Crops Table 8. Key Players of Cell Line Engineering Table 9. Global CRISPR-Based Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global CRISPR-Based Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global CRISPR-Based Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global CRISPR-Based Therapeutics Market Share by Regions (2016-2021) Table 13. Global CRISPR-Based Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global CRISPR-Based Therapeutics Market Share by Regions (2022-2027) Table 15. CRISPR-Based Therapeutics Market Trends Table 16. CRISPR-Based Therapeutics Market Drivers Table 17. CRISPR-Based Therapeutics Market Challenges Table 18. CRISPR-Based Therapeutics Market Restraints Table 19. Global CRISPR-Based Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 20. Global CRISPR-Based Therapeutics Market Share by Players (2016-2021) Table 21. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR-Based Therapeutics as of 2020) Table 22. Ranking of Global Top CRISPR-Based Therapeutics Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by CRISPR-Based Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players CRISPR-Based Therapeutics Product Solution and Service Table 26. Date of Enter into CRISPR-Based Therapeutics Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 29. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2016-2021) Table 30. Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global CRISPR-Based Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2016-2021) Table 34. Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 37. North America CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 38. North America CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 39. North America CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 40. North America CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 41. North America CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 43. Europe CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 45. Europe CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 66. Caribou Biosciences Company Details Table 67. Caribou Biosciences Business Overview Table 68. Caribou Biosciences CRISPR-Based Therapeutics Product Table 69. Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 70. Caribou Biosciences Recent Development Table 71. Addgene Company Details Table 72. Addgene Business Overview Table 73. Addgene CRISPR-Based Therapeutics Product Table 74. Addgene Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 75. Addgene Recent Development Table 76. CRISPR THERAPEUTICS Company Details Table 77. CRISPR THERAPEUTICS Business Overview Table 78. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Product Table 79. CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 80. CRISPR THERAPEUTICS Recent Development Table 81. Merck KGaA Company Details Table 82. Merck KGaA Business Overview Table 83. Merck KGaA CRISPR-Based Therapeutics Product Table 84. Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 85. Merck KGaA Recent Development Table 86. Mirus Bio LLC Company Details Table 87. Mirus Bio LLC Business Overview Table 88. Mirus Bio LLC CRISPR-Based Therapeutics Product Table 89. Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 90. Mirus Bio LLC Recent Development Table 91. Editas Medicine Company Details Table 92. Editas Medicine Business Overview Table 93. Editas Medicine CRISPR-Based Therapeutics Product Table 94. Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 95. Editas Medicine Recent Development Table 96. Takara Bio USA Company Details Table 97. Takara Bio USA Business Overview Table 98. Takara Bio USA CRISPR-Based Therapeutics Product Table 99. Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 100. Takara Bio USA Recent Development Table 101. Thermo Fisher Scientific Company Details Table 102. Thermo Fisher Scientific Business Overview Table 103. Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 104. Thermo Fisher Scientific Recent Development Table 105. Horizon Discovery Group Company Details Table 106. Horizon Discovery Group Business Overview Table 107. Horizon Discovery Group CRISPR-Based Therapeutics Product Table 108. Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 109. Horizon Discovery Group Recent Development Table 110. Intellia Therapeutics Company Details Table 111. Intellia Therapeutics Business Overview Table 112. Intellia Therapeutics CRISPR-Based Therapeutics Product Table 113. Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 114. Intellia Therapeutics Recent Development Table 115. GE Healthcare Dharmacon Company Details Table 116. GE Healthcare Dharmacon Business Overview Table 117. GE Healthcare Dharmacon CRISPR-Based Therapeutics Product Table 118. GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million) Table 119. GE Healthcare Dharmacon Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global CRISPR-Based Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Genome Editing Features Figure 3. Genetic Engineering Features Figure 4. gRNA Database/Gene Librar Features Figure 5. CRISPR Plasmid Features Figure 6. Human Stem Cells Features Figure 7. Genetically Modified Organisms/Crops Features Figure 8. Cell Line Engineering Features Figure 9. Global CRISPR-Based Therapeutics Market Share by Application: 2020 VS 2027 Figure 10. Biotechnology Companies Case Studies Figure 11. Pharmaceutical Companies Case Studies Figure 12. Academic Institutes Case Studies Figure 13. Research and Development Institutes Case Studies Figure 14. CRISPR-Based Therapeutics Report Years Considered Figure 15. Global CRISPR-Based Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 16. Global CRISPR-Based Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global CRISPR-Based Therapeutics Market Share by Regions: 2020 VS 2027 Figure 18. Global CRISPR-Based Therapeutics Market Share by Regions (2022-2027) Figure 19. Global CRISPR-Based Therapeutics Market Share by Players in 2020 Figure 20. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR-Based Therapeutics as of 2020 Figure 21. The Top 10 and 5 Players Market Share by CRISPR-Based Therapeutics Revenue in 2020 Figure 22. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2016-2021) Figure 23. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2022-2027) Figure 24. North America CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. North America CRISPR-Based Therapeutics Market Share by Type (2016-2027) Figure 26. North America CRISPR-Based Therapeutics Market Share by Application (2016-2027) Figure 27. North America CRISPR-Based Therapeutics Market Share by Country (2016-2027) Figure 28. United States CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Canada CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe CRISPR-Based Therapeutics Market Share by Type (2016-2027) Figure 32. Europe CRISPR-Based Therapeutics Market Share by Application (2016-2027) Figure 33. Europe CRISPR-Based Therapeutics Market Share by Country (2016-2027) Figure 34. Germany CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. France CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. U.K. CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Italy CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Russia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Nordic CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific CRISPR-Based Therapeutics Market Share by Type (2016-2027) Figure 42. Asia-Pacific CRISPR-Based Therapeutics Market Share by Application (2016-2027) Figure 43. Asia-Pacific CRISPR-Based Therapeutics Market Share by Region (2016-2027) Figure 44. China CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Japan CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. South Korea CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Southeast Asia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. India CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Australia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America CRISPR-Based Therapeutics Market Share by Type (2016-2027) Figure 52. Latin America CRISPR-Based Therapeutics Market Share by Application (2016-2027) Figure 53. Latin America CRISPR-Based Therapeutics Market Share by Country (2016-2027) Figure 54. Mexico CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Brazil CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa CRISPR-Based Therapeutics Market Share by Type (2016-2027) Figure 58. Middle East & Africa CRISPR-Based Therapeutics Market Share by Application (2016-2027) Figure 59. Middle East & Africa CRISPR-Based Therapeutics Market Share by Country (2016-2027) Figure 60. Turkey CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Saudi Arabia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. UAE CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Caribou Biosciences Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 64. Addgene Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 65. CRISPR THERAPEUTICS Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 66. Merck KGaA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 67. Mirus Bio LLC Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 68. Editas Medicine Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 69. Takara Bio USA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 70. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 71. Horizon Discovery Group Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 72. Intellia Therapeutics Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 73. GE Healthcare Dharmacon Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Caribou Biosciences Addgene CRISPR THERAPEUTICS Merck KGaA Mirus Bio LLC Editas Medicine Takara Bio USA Thermo Fisher Scientific Horizon Discovery Group Intellia Therapeutics GE Healthcare Dharmacon